Medicine Science (Sep 2023)

Annexin A3 levels in patients with schizophrenia and bipolar disorder

  • Alpaslan Ozturk,
  • Mehmet Ali Gul,
  • Derya Canli,
  • Elif Menekse

DOI
https://doi.org/10.5455/medscience.2023.07.116
Journal volume & issue
Vol. 12, no. 3
pp. 853 – 8

Abstract

Read online

Schizophrenia and bipolar disorder are disorders characterized by alterations in cellular and molecular mechanisms. Annexin A3 (ANXA3) has various effects on neural mechanisms and membrane phospholipid function and both mechanisms are thought to be associated with psychotic disorders. Our study consisted of 93 schizophrenia and bipolar disorder and 52 healthy controls. ANXA3 was analyzed by enzyme-linked immunosorbent assay (ELISA). ANXA3 levels were significantly different between the groups (p [Med-Science 2023; 12(3.000): 853-8]

Keywords